Wells Fargo’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Buy |
27,356
+25,112
| +1,119% | +$283K | ﹤0.01% | 4110 |
|
|
2025
Q1 | $12.8K | Buy |
2,244
+1,852
| +472% | +$10.6K | ﹤0.01% | 5374 |
|
|
2024
Q4 | $3.85K | Sell |
392
-244
| -38% | -$2.4K | ﹤0.01% | 5600 |
|
|
2024
Q3 | $5.18K | Sell |
636
-638
| -50% | -$5.2K | ﹤0.01% | 5500 |
|
|
2024
Q2 | $17K | Sell |
1,274
-775
| -38% | -$10.4K | ﹤0.01% | 5247 |
|
|
2024
Q1 | $95.1K | Buy |
2,049
+163
| +9% | +$7.56K | ﹤0.01% | 4549 |
|
|
2023
Q4 | $127K | Sell |
1,886
-434
| -19% | -$29.3K | ﹤0.01% | 4358 |
|
|
2023
Q3 | $168K | Buy |
2,320
+151
| +7% | +$10.9K | ﹤0.01% | 4153 |
|
|
2023
Q2 | $161K | Buy |
2,169
+599
| +38% | +$44.6K | ﹤0.01% | 4468 |
|
|
2023
Q1 | $83.5K | Buy |
1,570
+358
| +30% | +$19.1K | ﹤0.01% | 4616 |
|
|
2022
Q4 | $82K | Sell |
1,212
-95
| -7% | -$6.42K | ﹤0.01% | 4338 |
|
|
2022
Q3 | $163K | Buy |
1,307
+178
| +16% | +$22.2K | ﹤0.01% | 4066 |
|
|
2022
Q2 | $107K | Buy |
1,129
+298
| +36% | +$28.2K | ﹤0.01% | 4343 |
|
|
2022
Q1 | $135K | Sell |
831
-4,037
| -83% | -$656K | ﹤0.01% | 4870 |
|
|
2021
Q4 | $1.62M | Buy |
4,868
+4,323
| +793% | +$1.44M | ﹤0.01% | 3471 |
|
|
2021
Q3 | $252K | Buy |
+545
| New | +$252K | ﹤0.01% | 4726 |
|